An Alkaline Nanocage Continuously Activates Inflammasomes by Disrupting Multiorganelle Homeostasis for Efficient Pyroptosis
Source abstract
Abstract
Pyroptosis has garnered increasing attention because of its ability to trigger robust antitumor immunity. Pyroptosis is initiated by the activation of inflammasomes, which are regulated by various organelles. The collaboration among organelles offers several protective mechanisms to prevent activation of the inflammasome, thereby limiting the induction of efficient pyroptosis. Herein, a multiorganelle homeostasis disruptor (denoted BLL) is constructed by encapsulating liposomes and bortezomib (BTZ) within a layered double hydroxide (LDH) nanocage to continuously activate inflammasomes for inducing efficient pyroptosis. In lysosomes, the negatively charged liposomes are released to recruit the NLRP3 inflammasomes through electrostatic interactions. ER stress is induced by BTZ to enhance the activation of the NLRP3 inflammasome. Meanwhile, the BLL nanocage exhibited H + -scavenging ability due to the weak alkalinity of LDH, thus disrupting the homeostasis of the lysosome and alleviating the degradation of the NLRP3 inflammasome by lysosomal-associated autophagy. Our results suggest that the BLL nanocage induces homeostatic imbalance in various organelles and efficient pyroptosis. We hope this work can provide new insights into the design of an efficient pyroptosis inducer by disrupting the homeostatic balance of multiple organelles and promote the development of novel antineoplastic platforms.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Inflammasome and immune disorders · Heme Oxygenase-1 and Carbon Monoxide · Toxoplasma gondii Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Rare Earth Resources Utilization and Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, P. R. China
School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, Anhui 230029, P. R. China
Funding
National Key Research and Development Program of China · People's Government of Jilin Province · National Natural Science Foundation of China
References (57)
Show source-provided references
1. 10.1038/s41577-019-0228-210.1038/s41577-019-0228-2 ↗
2. 10.1038/s41573-021-00154-z10.1038/s41573-021-00154-z ↗
3. 10.1002/anie.20201028110.1002/anie.202010281 ↗
4. 10.1038/s41467-022-34036-810.1038/s41467-022-34036-8 ↗
5. 10.1038/nri.2016.14710.1038/nri.2016.147 ↗
6. 10.1002/anie.20201639910.1002/anie.202016399 ↗
7. 10.1002/adma.20230023210.1002/adma.202300232 ↗
8. 10.1002/adma.20231006310.1002/adma.202310063 ↗
9. 10.1038/nature1859010.1038/nature18590 ↗
10. 10.1038/nature1551410.1038/nature15514 ↗
11. 10.1038/nature1862910.1038/nature18629 ↗
12. 10.1038/s41590-022-01355-310.1038/s41590-022-01355-3 ↗
13. 10.1126/science.aas899510.1126/science.aas8995 ↗
14. 10.1038/s41578-021-00396-810.1038/s41578-021-00396-8 ↗
15. 10.1038/s41568-020-00312-210.1038/s41568-020-00312-2 ↗
16. 10.1002/adma.20220686110.1002/adma.202206861 ↗
17. 10.1002/adma.20200742610.1002/adma.202007426 ↗
18. 10.1002/adma.20230539410.1002/adma.202305394 ↗
19. 10.1038/s41467-019-09397-210.1038/s41467-019-09397-2 ↗
20. 10.1021/jacs.3c0418010.1021/jacs.3c04180 ↗
21. 10.1038/s41565-022-01125-010.1038/s41565-022-01125-0 ↗
22. 10.1016/j.immuni.2015.08.00810.1016/j.immuni.2015.08.008 ↗
23. 10.1002/anie.20220490410.1002/anie.202204904 ↗
24. 10.1002/anie.20200190610.1002/anie.202001906 ↗
25. 10.1126/sciadv.abb872510.1126/sciadv.abb8725 ↗
26. 10.1038/nrm356510.1038/nrm3565 ↗
27. 10.1038/s41580-023-00585-z10.1038/s41580-023-00585-z ↗
28. 10.1038/s41580-019-0185-410.1038/s41580-019-0185-4 ↗
29. 10.3389/fimmu.2022.82610610.3389/fimmu.2022.826106 ↗
30. 10.1016/j.arr.2023.10195110.1016/j.arr.2023.101951 ↗
31. 10.1038/s41418-017-0033-z10.1038/s41418-017-0033-z ↗
32. 10.1016/j.semcancer.2019.11.00710.1016/j.semcancer.2019.11.007 ↗
33. 10.1038/nature1449810.1038/nature14498 ↗
34. 10.1002/adma.20221159710.1002/adma.202211597 ↗
35. 10.1152/physrev.00038.202110.1152/physrev.00038.2021 ↗
36. 10.1038/s41586-019-1295-z10.1038/s41586-019-1295-z ↗
37. 10.1038/s41586-018-0761-310.1038/s41586-018-0761-3 ↗
38. 10.1016/j.immuni.2013.08.00110.1016/j.immuni.2013.08.001 ↗
39. 10.1073/pnas.212135311910.1073/pnas.2121353119 ↗
40. 10.1021/acsnano.2c0218310.1021/acsnano.2c02183 ↗
41. 10.1002/adma.20220691510.1002/adma.202206915 ↗
42. 10.1021/acsnano.2c1083010.1021/acsnano.2c10830 ↗
43. 10.1016/j.apsb.2021.05.03110.1016/j.apsb.2021.05.031 ↗
44. 10.1016/j.jconrel.2023.11.05110.1016/j.jconrel.2023.11.051 ↗
45. 10.1021/acsnano.3c1305610.1021/acsnano.3c13056 ↗
46. 10.1021/jacs.0c1028510.1021/jacs.0c10285 ↗
47. 10.1002/anie.20221691710.1002/anie.202216917 ↗
48. 10.1002/anie.20221530710.1002/anie.202215307 ↗
49. 10.1016/j.tox.2023.15358210.1016/j.tox.2023.153582 ↗
50. 10.1038/ni.327310.1038/ni.3273 ↗
51. 10.1038/ncomms1412410.1038/ncomms14124 ↗
52. 10.1126/sciadv.abl644910.1126/sciadv.abl6449 ↗
53. 10.3390/molecules2308194110.3390/molecules23081941 ↗
54. 10.1038/s41467-017-01609-x10.1038/s41467-017-01609-x ↗
55. 10.1038/s41467-023-39172-310.1038/s41467-023-39172-3 ↗
56. 10.1002/adma.20190715210.1002/adma.201907152 ↗
57. 10.3390/ijms2024611210.3390/ijms20246112 ↗